1. Medtech Insight
  2. >>Policy & Regulation

BioVentrix Continues Battle To Remodel Post-Attack Hearts

 
• By Barnaby Pickering

Following reimbursement approval in Germany, BioVentrix is making headway in long-neglected post-heart attack treatments.

Transcatheter Device
BioVentrix's Revivent TC • Source: BioVentrix, Inc.

BioVentrix, a California company specializing in ventricular remodeling for heart attack patients, is continuing to make clinical progress in a field of medicine where so many other companies have failed.

The company’s Revivent TC device has successfully obtained reimbursement in a number of countries, most recently in Germany on 8 February. Alongside the German market, BioVentrix is targeting other European...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Policy & Regulation

More from Medtech Insight

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 
• By Natasha Barrow

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By Ashley Yeo

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 
• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.